New ankle implant aims to get patients walking weeks sooner

NCT ID NCT06085586

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests a new surgical implant called Fibulink for repairing ankle fractures with torn ligaments. The goal is to see if it allows patients to start walking fully at 4 weeks instead of the usual 6 weeks, without the implant failing. 56 adults with specific ankle injuries will be enrolled and followed for 6 months to check if the ankle stays properly aligned.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Fibulink Syndesmosis Repair System (a surgical implant)
What this could lead to
If successful, this could allow patients to walk sooner after ankle surgery, potentially speeding up recovery and reducing long-term joint damage.
What could go wrong
This is a small, early-stage study with only 56 participants. The device may not maintain ankle alignment as hoped, and earlier weight bearing could increase the risk of implant failure or re-injury.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANKLE DISLOCATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Ankle Fractures ankle injury Fibula Fractures

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Maimonides Medical Center

    RECRUITING

    Brooklyn, New York, 11219, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.